Premarin combined with Vivelle

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Breast Cancer Other Serious 4/5/2001 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2000 50 Female 160 lb 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 5/30/2000 58 Female 120 lb 12/23/2005 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 1/25/2002 Female 2/28/2006 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 1/25/2002 Female 3/1/2006 United States
Primary
Secondary
Breast Cancer In Situ Other Serious 6/6/2003 62 Female 3/20/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 9/14/1999 60 Female 3/28/2006 Lawyer United States
Primary
Secondary
Weight Increased Hospitalization 10/13/1998 56 Female 172 lb 4/5/2006 Physician United States
Primary
Secondary
Concomitant
Menopausal Symptoms Other Serious 5/1/1997 55 Female 182 lb 5/2/2006 Pharmacist United States
Primary
Secondary
Concomitant
Oestrogen Receptor Assay Positive Other Serious 3/7/2002 Female 4/28/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2000 Female 7/12/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 1/1/2000 Female 7/17/2006 United States
Primary
Secondary
Breast Cancer Required Intervention Female 6/15/2006 Lawyer United States
Primary
Secondary
Mastectomy Other Serious Female 8/31/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 6/6/2003 62 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/25/2002 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 6/1/2004 53 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 4/1/2001 58 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 6/1/2004 53 Female 9/18/2006 Lawyer United States
Primary
Secondary
Vocal Cord Thickening Other Serious 1/1/1999 51 Female 195 lb 2/28/2007 United States
Primary
Secondary
Concomitant
Vulvovaginal Mycotic Infection Other Serious 1/1/1995 51 Female 170 lb 2/28/2007 United States
Primary
Secondary
Concomitant
Ventricular Extrasystoles Other Serious 11/20/1998 Female 3/7/2007 United States
Primary
Secondary
Ventricular Dysfunction Other Serious 2/1/1991 58 Female 3/15/2007 Physician United States
Primary
Secondary
Uterine Leiomyoma Other Serious 1/1/1995 51 Female 3/27/2007 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 4/1/2002 61 Female 198 lb 3/28/2007 United States
Primary
Secondary
Concomitant
Ultrasound Breast Abnormal Other Serious 1/1/2000 60 Female 180 lb 3/28/2007 Lawyer United States
Primary
Secondary
Concomitant
Mastectomy Other Serious 1/25/2002 Female 11/3/2006 Lawyer United States
Primary
Secondary
Mastectomy Other Serious 62 Female 11/3/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious Female 11/3/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 4/1/2001 58 Female 11/3/2006 Lawyer United States
Primary
Secondary
Breast Operation Other Serious Female 10/30/2006 Lawyer United States
Primary
Secondary
Scar Other Serious Female 10/30/2006 Lawyer United States
Primary
Secondary
Scar Other Serious Female 10/30/2006 Lawyer United States
Primary
Secondary
Pulmonary Embolism Other Serious Male 10/30/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 11/14/2002 59 Female 165 lb 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 9/14/1999 60 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2000 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/25/2002 Female 1/31/2007 Consumer United States
Primary
Secondary
Ventricular Extrasystoles Other Serious 4/1/2000 59 Female 5/10/2007 Physician United States
Primary
Secondary
Concomitant
Breast Cancer In Situ Other Serious 12/27/2001 56 Female 138 lb 2/7/2007 Physician United States
Primary
Secondary
Irritable Bowel Syndrome Other Serious 7/7/1998 65 Female 185 lb 2/7/2007 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious Female 4/6/2007 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Vision Blurred Other Serious 12/15/1994 66 Female 125 lb 7/9/2007 United States
Primary
Secondary
Uterine Prolapse Other Serious 1/1/1994 56 Female 7/18/2007 United States
Primary
Secondary
Wound Debridement Other Serious 1/1/1999 62 Female 150 lb 8/3/2007 United States
Primary
Secondary
Concomitant
Tubal Ligation Other Serious 1/1/1993 55 Female 155 lb 8/3/2007 Lawyer United States
Primary
Secondary
Concomitant
Uterine Leiomyoma Other Serious 11/29/1996 51 Female 138 lb 8/23/2007 United States
Primary
Secondary
Uterine Leiomyoma Other Serious 8/1/2002 54 Female 145 lb 10/16/2007 United States
Primary
Secondary
Concomitant
Wound Drainage Other Serious 10/20/1998 58 Female 10/23/2007 United States
Primary
Secondary
Uterine Leiomyoma Other Serious 11/21/1989 51 Female 11/3/2007 United States
Primary
Secondary
Ultrasound Breast Abnormal Other Serious 1/1/2000 11/3/2007 United States
Primary
Secondary
Concomitant
Progesterone Receptor Assay Positive Other Serious 4/1/2002 61 Female 190 lb 11/3/2007 United States
Primary
Secondary
Concomitant
Uterine Leiomyoma Other Serious 1/1/1993 59 Female 165 lb 9/17/2007 Lawyer United States
Primary
Secondary
Concomitant
Ultrasound Doppler Abnormal Hospitalization 50 Female 179 lb 9/17/2007 Lawyer United States
Primary
Secondary
Uterine Leiomyoma Other Serious 4/13/1998 52 Female 225 lb 9/17/2007 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer In Situ Other Serious 12/27/2001 57 Female 139 lb 1/10/2008 Physician United States
Primary
Secondary
Concomitant
Uterine Prolapse Other Serious 1/1/1994 56 Female 1/10/2008 United States
Primary
Secondary
Wound Secretion Other Serious 10/20/1998 53 Female 156 lb 1/21/2008 United States
Primary
Secondary
Simple Mastectomy Other Serious 1/1/2000 58 Female 130 lb 11/5/2007 Physician United States
Primary
Secondary
Concomitant
Thrombosis Other Serious 42 Female 224 lb 11/5/2007 Lawyer United States
Primary
Secondary
Wound Closure Other Serious 1/1/1999 62 Female 150 lb 1/23/2008 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 7/1/2002 Female 12/18/2007 United States
Primary
Secondary
Breast Cancer Other Serious 5/30/2000 58 Female 120 lb 12/18/2007 United States
Primary
Secondary
Concomitant
Surgery Other Serious 5/3/1998 52 Female 155 lb 3/27/2008 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 1/1/2003 Female 4/1/2008 Lawyer United Kingdom
Primary
Secondary
Systemic Lupus Erythematosus Other Serious 1/1/1988 Female 125 lb 4/4/2008 Lawyer United States
Primary
Secondary
White Blood Cell Count Decreased Other Serious 1/1/1994 56 Female 157 lb 4/8/2008 United States
Primary
Secondary
Concomitant
Wound Closure Other Serious 1/1/1999 62 Female 150 lb 4/22/2008 United States
Primary
Secondary
Concomitant
Breast Cancer Metastatic Other Serious 4/13/1999 Female 195 lb 5/22/2008 Consumer United States
Primary
Secondary
Wound Drainage Other Serious 10/20/1998 Female 156 lb 5/27/2008 United States
Primary
Secondary
Surgery Other Serious 5/3/1998 Female 155 lb 6/13/2008 United States
Primary
Secondary
Concomitant
Breast Cancer Metastatic Other Serious 4/13/1999 Female 195 lb 6/13/2008 Consumer United States
Primary
Secondary
Uterine Leiomyoma Other Serious 11/29/1996 Female 138 lb 6/18/2008 United States
Primary
Secondary
White Blood Cell Count Decreased Other Serious 1/1/1994 Female 157 lb 6/19/2008 United States
Primary
Secondary
Concomitant
Breast Cancer Metastatic Other Serious 6/9/2004 Female 6/20/2008 Consumer United States
Primary
Secondary
Urinary Tract Infection Other Serious 1/6/1993 Female 6/24/2008 United States
Primary
Secondary
Squamous Cell Carcinoma Of Skin Other Serious 1/1/1993 Female 155 lb 7/10/2008 Lawyer United States
Primary
Secondary
Concomitant
Interacting
Wound Closure Other Serious 1/1/1998 Female 150 lb 7/15/2008 United States
Primary
Secondary
Concomitant
Vision Blurred Other Serious 12/15/1994 Female 125 lb 7/31/2008 United States
Primary
Secondary
Uterine Leiomyoma Other Serious 11/29/1996 Female 138 lb 7/30/2008 United States
Primary
Secondary

Drug Data